Search in:

Advanced search

Baylor University Medical Center Proceedings

The peer-reviewed journal of Baylor Scott & White Health

Volume 35, 2022 - Issue 3

Submit an article Journal homepage

Views

CrossRef citations to date

Altmetric

Case Studies

Effectiveness of casirivimab/imdevimab in an intensive care unit patient with acute respiratory failure due to SARS-CoV-2 infection

Benjamin Sloana Texas A&M College of Medicine, College Station, Texas

, BA,

Erin Duhaimeb Division of Infectious Diseases, Baylor University Medical Center, Dallas, Texas

, PA-C,

Uriel Sandkovskyb Division of Infectious Diseases, Baylor University Medical Center, Dallas, Texas

, MD, MS &

Mezgebe Berheb Division of Infectious Diseases, Baylor University Medical Center, Dallas, TexasCorrespondence[email protected]

, MD, MPH

Pages 339-341 | Received 10 Dec 2021, Accepted 10 Feb 2022, Published online: 03 Mar 2022

Cite this article
https://doi.org/10.1080/08998280.2022.2042033
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:https://doi.org/10.1016/S0140-6736(20)30566-3.
PubMed Web of Science ®Google Scholar
COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/. Accessed September 7, 2021.
Google Scholar
Weinreich DM, Sivapalasingam S, Norton T, et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med. 2021;384(3):238–251. doi:https://doi.org/10.1056/NEJMoa2035002.
PubMed Web of Science ®Google Scholar
Anderson B, Smith Z, Edupuganti S, Yan X, Masi CM, Wu HM. Effect of monoclonal antibody treatment on clinical outcomes in ambulatory patients with coronavirus disease 2019. Open Forum Infect Dis. 2021;8(7):ofab315. doi:https://doi.org/10.1093/ofid/ofab315.
PubMedGoogle Scholar
O’Brien MP, Forleo-Neto E, Musser BJ, et al. Subcutaneous REGEN-COV antibody combination to prevent Covid-19. N Engl J Med. 2021;385(13):1184–1195. doi:https://doi.org/10.1056/NEJMoa2109682.
PubMed Web of Science ®Google Scholar
Kaila V, Sirkeoja S, Blomqvist S, et al. SARS-CoV-2 late shedding may be infectious between immunocompromised hosts. Infect Dis (Lond). 2021;53(11):880–882. doi:https://doi.org/10.1080/23744235.2021.1939891.
PubMed Web of Science ®Google Scholar
RECOVERY Collaborative Group. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. Lancet. 2021;397(10289):2049–2059. doi:https://doi.org/10.1016/S0140-6736(21)00897-7.
PubMed Web of Science ®Google Scholar
ACTIV-3/TICO Bamlanivimab Study Group. Responses to a neutralizing monoclonal antibody for hospitalized patients with COVID-19 according to baseline antibody and antigen levels: a randomized controlled trial. Ann Intern Med. 2022:175:234–243. doi:https://doi.org/10.7326/M21-3507.
Google Scholar
Self W, Sandkovsky U, on behalf of TICO/ACTIV-3 study group. Neutralizing monoclonal antibody therapies VIR-7831 and BRII-196/198 for adults hospitalized with Covid-19: a randomized controlled trial. Lancet Infect Dis. 2021;S1473–3099(21)00751-9. doi:https://doi.org/10.1016/S1473-3099(21)00751-9.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Effectiveness of casirivimab/imdevimab in an intensive care unit patient with acute respiratory failure due to SARS-CoV-2 infection

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Effectiveness of casirivimab/imdevimab in an intensive care unit patient with acute respiratory failure due to SARS-CoV-2 infection

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date